Missing/wrong data?
Log in to edit
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma
scientific article
Author/s
author: Henry Seth Friedman, Annick Desjardins, Frances McSherry, James J Vredenburgh, Katherine B Peters, James H. Herndon, Eric Lipp, Mary Lou Affronti
Work details
Publication date
April 17, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.